nadp has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D; He, X; Jia, L; Jin, L; Ouyang, Y; Ren, X; Tian, Z; Wang, Y; Wu, D; Yang, Z; Zhou, Y | 1 |
| Cho, ES; Cho, SB; Kim, HS; Kim, NH; Yook, JI; Yun, JS | 1 |
| Dai, J; Hammoudi, N; Huang, P; Liu, J; Pelicano, H; Pusztai, L; Xu, RH; Zhang, W | 1 |
3 other study(ies) available for nadp and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
NADPH Selective Depletion Nanomedicine-Mediated Radio-Immunometabolism Regulation for Strengthening Anti-PDL1 Therapy against TNBC.
Topics: Humans; NADP; Nanomedicine; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |
Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism.
Topics: Acetyl-CoA Carboxylase; Adenosine Triphosphate; Breast Neoplasms; Cell Survival; Epithelial-Mesenchymal Transition; Female; Fructose-Bisphosphatase; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; NADP; Oxidation-Reduction; Pentose Phosphate Pathway; Phosphofructokinase-1, Type C; Snail Family Transcription Factors; Triple Negative Breast Neoplasms | 2020 |
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
Topics: Adenosine Triphosphate; Cell Line, Tumor; Electron Transport Chain Complex Proteins; Energy Metabolism; Female; Glucose; Glutathione; Humans; Hydrocarbons, Brominated; Lactic Acid; Mitochondria; NADP; Oxidation-Reduction; Oxygen Consumption; Propionates; Reactive Oxygen Species; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms | 2014 |